Clinical Trial Update: Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating oxaliplatin plus bevacizumab in germ cell tumor patients has completed enrollment. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Embryonal Tumor
• Germ Cell Tumor

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)

Snippet

Sponsor: Indiana University | Conditions: Neoplasms, Germ Cell and Embryonal | Phase 2 | Status: COMPLETED | Results posted: 2015-01-29